FindTrial
Sign In

Amount of antibody produced by new coronavirus vaccination of young Japanese people.

Amount of antibody produced by COVID-19 vaccination of mRNA-1273(Takeda/Moderna) and BNT162b2(Pfizer/BioNTech) in Japanese youth. - Amount of antibody produced by COVID-19 vaccination of Japanese youth.

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000045551
Enrollment
250
Registered
2021-09-24
Start date
2021-09-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Sponsors

Nishikyushu University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The following students of our university. 1. Among current students, persons over 18 years old who have received two doses of Pfizer's SARS-CoV-2 vaccine in and have been vaccinated for at least two weeks, and who can consent to donating a sample (50 persons). 2. Persons over 18 years old who have received two doses of Moderna's SARS-CoV-2 vaccine and have been vaccinated for at least two weeks, and who can consent to donating a sample (200 persons).

Exclusion criteria

Exclusion criteria: Those who do not meet the selection criteria

Design outcomes

Primary

MeasureTime frame
IgG antibody level of new corona vaccinated person.—

Countries

Japan

Contacts

Public ContactYuko Hisatomi

Nishikyushu University Installation preparation room and Faculty of Health and Nutrition Sciences

hisatomiyu@nisikyu-u.ac.jp0952-52-4191

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026